Clinical Trials Browser

Phase 1 × Triple Negative Breast Neoplasms × pirarubicin × Clear all

NCT07178171 2025-11-24

A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC

Phase 1 Recruiting

Triple Negative Breast Neoplasms